| Korea's First Tailored Cognitive Intervention Program Opens New Path for Dementia Prevention and Treatment
| Optimized Solution for Mild Cognitive Impairment and Dementia Patients Facing Memory Decline
| Emphasis on Personalized Training Based on Cognitive Intervention Therapy and Clinical Utility

Rowan Inc. (CEO: Seunghyun Han, Sungmin Kang) successfully concluded the ‘SuperBrain H Launch Symposium’ held on December 7th at Mondrian Seoul Itaewon Hotel in Yongsan-gu, Seoul, marking a new milestone in the digital cognitive intervention therapy market.

‘SuperBrain H’ Offers New Solution for Cognitive Disorder Treatment
‘SuperBrain H’ is Korea’s first tailored cognitive intervention program specifically designed for Korean individuals. It provides a cognitive function improvement solution for patients experiencing memory decline and early-stage dementia. The symposium was structured around various topics, including △'A New Paradigm for Cognitive Disorder Treatment,' △'Clinical Effectiveness of SuperBrain H,' and △'First Steps and Setup for SuperBrain H.'

The event saw the participation of neurologists from across the country, as well as clinical psychologists, occupational therapists, and nurses, who work closely with patients. These professionals engaged in in-depth discussions on the program's clinical effects and practical applications.

Expanding Global Potential of Digital Therapeutics
During the symposium’s discussions, experts highlighted that “The digital therapeutics field is still in its early stages globally. Therefore, cases like SuperBrain H, which have verified evidence through clinical trials with over 1,000 participants, are very rare. In the future, we expect more therapies combining high efficacy and cost-effectiveness, contributing to preserving the valuable memories of patients with cognitive decline.”

Seunghyun Han, CEO of Rowan Inc., stated, “SuperBrain H is a product that provides practical help to both medical professionals and patients. We will do our best to provide new hope to cognitive disorder patients worldwide through our expansion into the global market.” The symposium demonstrated the practical effects and potential of SuperBrain H, solidifying Rowan Inc.'s leading position in the digital therapeutics market.

On December 7th, Rowan Inc. hosted the SuperBrain H Launch Symposium at Mondrian Seoul Itaewon Hotel in Yongsan-gu, Seoul. Neurologists and therapists in attendance listened to lectures in the event’s banquet hall.